|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.73/-0.88
|
企业价值
15.15M
|
资产负债 |
每股账面净值
-0.17
|
现金流量 |
现金流量率
--
|
损益表 |
收益
0
|
每股收益
0.01
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/03 22:14 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer. |